Healthcare - Biotechnology - NASDAQ - US
$ 189.23
-2.1 %
$ 21 B
Market Cap
-23.08
P/E
CASH FLOW STATEMENT
-1.16 B
OPERATING CASH FLOW
60 M
INVESTING CASH FLOW
416 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
BeiGene, Ltd.
| Net Income | -882 M |
| Depreciation & Amortization | 87.7 M |
| Capital Expenditures | -581 M |
| Stock-Based Compensation | 368 M |
| Change in Working Capital | -371 M |
| Others | -424 M |
| Free Cash Flow | -1.74 B |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (881.7) | (2 003.8) | (1 413.4) | (1 600.5) | (950.6) | (674.0) | (93.3) | (119.2) | (57.1) | (18.5) | (7.9) |
| Depreciation & Amortization | 87.7 | 66.3 | 46.5 | 31.8 | 18.6 | 10.4 | 4.8 | 1.9 | 1.5 | 1.6 | 1.6 |
| Deferred Income Tax | 0.7 | 2.1 | (41.1) | (27.8) | (9.2) | (21.9) | (5.8) | (0.8) | 2.1 | 70 K | (0.1) |
| Stock Based Compensation | 367.6 | 303.2 | 240.7 | 183.5 | 134.2 | 87.1 | 42.9 | 10.6 | 10.2 | 6.6 | 24 K |
| Other Operating Activities | (361.2) | 3.3 | (13.1) | (21.0) | 67.6 | 68.0 | 7.1 | 3.8 | 1.1 | 3.3 | 2.8 |
| Change in Working Capital | (370.5) | 132.4 | (118.3) | 150.6 | (10.8) | (17.2) | 57.2 | 14.1 | 2.3 | (1.5) | 7.7 |
| Cash From Operations | (1 157.5) | (1 496.6) | (1 298.7) | (1 283.5) | (750.3) | (547.7) | 12.8 | (89.5) | (39.8) | (8.7) | 4.1 |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (581.3) | (469.1) | (314.9) | (229.0) | (158.6) | (140.8) | (58.7) | (23.5) | (5.3) | (0.7) | (0.3) |
| Other Items | 641.3 | 1 546.2 | 955.5 | (2 939.3) | 712.8 | (496.8) | (297.6) | (198.3) | (53.6) | (33.0) | 14 K |
| Cash From Investing Activities | 60.0 | 1 077.1 | 640.7 | (3 168.4) | 554.2 | (637.6) | (356.3) | (221.8) | (58.9) | (33.6) | (0.2) |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75 K | 80 K | 0 |
| Total Debt Repaid | 360.8 | (65.9) | 101.5 | 289.6 | 34.7 | 33.6 | 132.8 | 12.0 | 5.9 | 17.8 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 55.7 | 47.0 | 3 535.4 | 4 913.2 | 51.0 | 29.7 | 18.5 | 23 K | 194.6 | 34.3 | (0.5) |
| Cash From Financing Activities | 416.5 | (19.0) | 3 636.9 | 5 202.8 | 85.7 | 1 690.5 | 490.4 | 380.9 | 103.2 | 52.2 | (0.5) |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | (689.1) | (507.9) | 2 992.9 | 769.2 | (119.9) | 501.1 | 152.1 | 69.6 | 4.0 | 10.0 | 3.3 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (1 738.7) | (1 965.7) | (1 613.6) | (1 512.5) | (908.9) | (688.6) | (46.0) | (113.0) | (45.2) | (9.3) | 3.8 |